**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7080-50-4 |Chloramine-T Trihydrate, 98% | 98% | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Air sensitive.
Potential Health Effects
Eye:
May cause eye irritation. Dusts may cause persistent eye
irritation and conjunctivitis.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, breath shortness,
cyanosis with bluish skin, rapid heart rate and chocolate-brown
colored blood. This product contains nitrite which may cause
methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, breath shortness,
cyanosis with bluish skin, rapid heart rate and chocolate-brown
blood. Inhalation of dust may cause respiratory tract irritation.
This product contains nitrite which may cause methemoglobinemia.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Get medical aid immediately. Remove from exposure to fresh air
immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
blue depending on the methemoglobinemia concentration in the blood.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep containers tightly closed. Do not
expose to air.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29CFR
1910.134 or European Standard EN 149. Always use a
NIOSH or European Standard EN 149 approved respirator
when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Appearance: white or yellow
Odor: mild odor - chlorine-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 177.00 - 170.00 deg C
Autoignition Temperature: Not available.
Flash Point: 192 deg C ( 377.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Moderately Soluble.
Specific Gravity/Density:
Molecular Formula: C7H7ClNO2SNa.3H2O
Molecular Weight: 281.69
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Exposure to air.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, oxides
of sulfur, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7080-50-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Chloramine-T Trihydrate, 98% -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Dangerous Goods Code:
UN Number:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 7 Keep container tightly closed.
S 15 Keep away from heat.
WGK (Water Danger/Protection)
CAS# 7080-50-4: No information available.
United Kingdom Occupational Exposure Limits
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7080-50-4 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 7080-50-4 is not on the TSCA Inventory. It is a hydrate and
exempt from TSCA Inventory requirements (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 10/13/1997 Revision #3 Date: 8/03/2001
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
n-Methyl-2,2,2-trifluoroacetamide, 98%
| 815-06-5 |
|
D-(+)-alpha-methylbenzylamine, 99+%,(99% e.e.)
| 3886-69-9 |
|
Rhodamine 123, 99+% (UV-Vis)
| 62669-70-9 |
|
3,5-Dimethylisoxazole, 99%
| 300-87-8 |
|
1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride, 99+%
| 56243-25-5 |
|
Inosine 5'-diphosphate, trisodium salt hydrate
| 81012-88-6 |
|
Azure b (cert)
| 531-55-5 |
|
Methyl propionate, 99+% (gc)
| 554-12-1 |
|
4,4'-Dimethoxybenzil, 99+%
| 1226-42-2 |
|
2-Aminobenzophenone, 98%
| 2835-77-0 |
|
Thallous ethoxide, 98%
| 20398-06-5 |
|
4-Amino-3-hydroxy-1-naphthalenesulfonic acid, reagent ACS, 98+%
| 116-63-2 |
|
N-Phenylmethanesulfonamide
| 1197-22-4 |
|
2'-Deoxyinosine, 99%
| 890-38-0 |
|
Naphthol AS-BI phosphate, 95% (titr.)
| 1919-91-1 |
|
o-Cresolphthalein complexone
| 2411-89-4 |
|
(R)-2-Hydroxy-3-buten-1-yl p-tosylate, 99% (gc)
| 138249-07-7 |
|
Isobutyronitrile, 99%
| 78-82-0 |
|
Betaine monohydrate, 99%
| 590-47-6 |
|
Amberlite XAD-2
| 9060-05-3 |
|
Shikimic Acid, 98%
| 138-59-0 |
|
(2r,3s)-1-carboxy-4-tert.-butyl-2,3-di-
| |
|
6-Methoxypurine, 99+%
| 1074-89-1 |
|
3,4,9,10-Perylenetetracarboxylic dianhydride, 98%
| 128-69-8 |
|
Pectin, Pract.
| 9000-69-5 |
|
Ethyl (2r)-2,3-epoxypropanoate, 97%
| 111058-33-4 |
|
3-Glycidoxypropyltrimethoxysilane, 97+%
| 2530-83-8 |
|
??3,4??-Dibenzo-21-Crown-7, 98%
| 14098-41-0 |
|
2-Chloro-6-methoxybenzonitrile, 97%
| 6575-10-6 |
|
Salicylhydrazide, 98%
| 936-02-7 |
|
Calcium Propionate, 98% (Titr., on Dry Basis)
| 4075-81-4 |
|
2-Bromofluorobenzene, 99%
| 1072-85-1 |
|
Plumbagin, 99+%
| 481-42-5 |
|
1-Iodohexadecane, 95% (GC)
| 544-77-4 |
|
2,3,5-Trichlorobenzaldehyde,97%
| 56961-75-2 |
|
N-Iodoacetyl-N'-(5-sulfo-1-naphthyl)- ethylenediamine
| 36930-63-9 |
|
Chloramine-T Trihydrate, 98%
| 7080-50-4 |
|
DL-Methionine Sulfoxide, 99%
| 454-41-1 |
|
4'-(Imidazol-1-yl)acetophenone, 97%
| 10041-06-2 |
|
Iproniazid Phosphate, 97%
| 305-33-9 |
|
Ethyl 3-thiopheneacetate, 98%
| 37784-63-7 |
|
2,6-Dimethoxyphenol, 99+% (gc)
| 91-10-1 |
|
o-Tolylurea
| 614-77-7 |
|
3,5-Dimethoxy-4-Hydroxybenzaldehyde, 98%
| 134-96-3 |
|
Lobeline Hydrochloride, 97%
| 63990-84-1 |
|
3',4'-Dichloroacetophenone, 99%
| 2642-63-9 |
|
2-Methyl-1,2,3,4-Tetrahydro-6,7-Isoquinolinediol Hydrochloride, 98%
| 63937-92-8 |
|
1-Benzyl-2-pyrrolidinone, 97%
| 5291-77-0 |
|
Benzopurpurin 4b, 95% (uv-vis)
| 992-59-6 |
|
7-Dehydrocholesterol, 97.5+%, Contains Approx. 1 Mole of MeOH of
| 434-16-2 |
|
|